Dacarbazine and malignant neoplasm progression Patient Reports February 11, 2012

Dacarbazine Side Effects Report #4871396-1
Dacarbazine side effect was reported by a Physician from UNITED STATES on Dec 16, 2005. Male patient, 84 years of age, weighting 194.0 lb, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: anorexia, atrial fibrillation , dehydration, fatigue, malignant neoplasm progression, metastatic malignant melanoma, pancytopenia, renal failure, sepsis . Dacarbazine dosage: unknown. During the same period patient was treated with VASOTEC, ONDANSETRON, COMPAZINE, INDAPAMIDE, METFORMIN, ENALAPRIL. Patient was hospitalized. Patient died on 12/12/2005.

Dacarbazine Side Effects Report #4920562-5
Dacarbazine side effect was reported by a Physician from UNITED STATES on Feb 06, 2006. Male patient, 70 years of age, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, metastatic malignant melanoma. Dacarbazine dosage: 227-2250MG/IV. Patient was hospitalized. Patient died on 01/19/2006.

Dacarbazine Side Effects Report #4917215-6
Dacarbazine side effect was reported by a Health Professional from UNITED STATES on Feb 01, 2006. Female patient, 62 years of age, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, metastatic malignant melanoma. Dacarbazine dosage: unknown. Patient died on 12/07/2005.

Dacarbazine Side Effects Report #5502741-1
Dacarbazine side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 16, 2007. Male patient, 60 years of age, weighting 156.5 lb, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: fall , head injury, malignant neoplasm progression, metastatic malignant melanoma, pleural effusion, skin haemorrhage. Dacarbazine dosage: 1880MG/IV. Patient was hospitalized. Patient died on 02/18/2006.


Dacarbazine Side Effects Report #4934204-6
Dacarbazine side effect was reported by a Physician from UNITED STATES on Jan 19, 2006. Male patient, 60 years of age, weighting 156.5 lb, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: fall , haematocrit decreased, haemoglobin decreased, intracranial tumour haemorrhage, malignant neoplasm progression, metastatic malignant melanoma, pleural effusion, pyrexia. Dacarbazine dosage: 1900-1880 MG* INTRAVENOUS. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #4934212-5
Dacarbazine side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 17, 2006. Male patient, 60 years of age, weighting 156.5 lb, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: disease progression, fall , haemorrhage, head injury, malignant neoplasm progression, metastatic malignant melanoma, pleural effusion. Dacarbazine dosage: 1880MG/IV. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #4963436-6
Dacarbazine side effect was reported by a Health Professional from UNITED STATES on Mar 20, 2006. Male patient, 60 years of age, weighting 156.5 lb, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: fall , haemorrhage, head injury, malignant neoplasm progression, metastatic malignant melanoma, pleural effusion, pyrexia. Dacarbazine dosage: 1880MG/IV. Patient was hospitalized. Patient died on 02/18/2006.

Dacarbazine Side Effects Report #4871393-6
Dacarbazine side effect was reported by a Pharmacist from UNITED STATES on Nov 11, 2005. Female patient, 46 years of age, weighting 169.8 lb, was diagnosed with metastatic malignant melanoma, computerised tomogram and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: anaphylactic reaction, blood pressure immeasurable, contrast media reaction, dehydration, loss of consciousness, lymphocyte count decreased, malignant neoplasm progression, nausea , pyrexia. Dacarbazine dosage: unknown. During the same period patient was treated with CONTRAST DYEECTABLE, OXYCODONE, OXYCONTIN, COMPAZINE. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #4917224-7
Dacarbazine side effect was reported by a Physician from UNITED STATES on Feb 01, 2006. Male patient, 45 years of age, was diagnosed with metastatic malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: disease progression, malignant neoplasm progression, metastatic malignant melanoma, nervous system disorder. Dacarbazine dosage: 2100MG/IV. Patient died on 12/20/2005.


Dacarbazine Side Effects Report #5413272-1
Dacarbazine side effect was reported by a Physician from AUSTRALIA on July 27, 2007. Female patient, 36 years of age, weighting 146.2 lb, was diagnosed with malignant melanoma stage iv and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: abdominal pain , malignant melanoma stage iv, malignant neoplasm progression, nausea . Dacarbazine dosage: 1700 MG Q3W IV. During the same period patient was treated with BOSENTAN, LORAZEPAM. Patient was hospitalized. Patient recovered.

Dacarbazine Side Effects Report #5743016-5
Dacarbazine side effect was reported by a Physician from UNITED KINGDOM on May 08, 2008. Male patient, 74 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: confusional state, hypotension, lethargy, leukocytosis, malignant neoplasm progression, rash , renal failure. Dacarbazine dosage: unknown. During the same period patient was treated with LISINOPRIL, DIGOXIN, AMLODIPINE, WARFARIN, SIMVASTATIN, BISOPROLOL FUMARATE, VITAMIN K. Patient was hospitalized. Patient died on 03/11/2008.

Dacarbazine Side Effects Report #6042214-3
Dacarbazine side effect was reported by a Physician from UNITED KINGDOM on Jan 14, 2009. Male patient, 74 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: confusional state, hypotension, lethargy, malignant neoplasm progression, rash , renal failure. Dacarbazine dosage: unknown. During the same period patient was treated with LISINOPRIL, DIGOXIN, AMLODIPINE BESYLATE, WARFARIN, SIMVASTATIN, BISOPROLOL, VITAMIN K. Patient was hospitalized. Patient died on 03/11/2008.

Dacarbazine Side Effects Report #5765353-0
Dacarbazine side effect was reported by a Physician from SPAIN on June 04, 2008. Male patient, 62 years of age, was diagnosed with malignant melanoma and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: arterial thrombosis limb, malignant neoplasm progression, peripheral sensory neuropathy. Dacarbazine dosage: unknown. Patient was hospitalized. Patient died on 03/26/2008.

Dacarbazine Side Effects Report #5142052-X
Dacarbazine side effect was reported by a Health Professional from POLAND on Oct 26, 2006. Male patient, 25 years of age, was diagnosed with hodgkin's disease  and was treated with Dacarbazine. After drug was administered, patient experienced the following side effects: granuloma, lung neoplasm, lymphadenopathy, malignant neoplasm progression, pulmonary sarcoidosis. Dacarbazine dosage: unknown. During the same period patient was treated with CORTICOSTEROID, DOXORUBICIN, BLEOMYCIN, VINBLASTINE SULPHATE. Patient recovered.